Home » Topics » BioWorld Science

BioWorld Science
RSS

CSPC cleared to begin clinical trials in China with SYHX-1901 for rheumatoid arthritis and SLE

March 19, 2021

Gilead describes compounds for Filoviridae virus infections

March 18, 2021

HBV caspid assembly inhibitors patented by Tibet Tiansheng Taifeng Pharmaceutical

March 18, 2021

New hydroxyacid oxidase 1 inhibitors discovered at OxaluRx

March 18, 2021

Hefei Institutes of Physical Sciences presents new PDGFR-alpha and/or PDGFR-beta inhibitors

March 18, 2021

PDE4 inhibitors divulged by Hubei Bio-Pharmaceutical, Humanwell Healthcare

March 18, 2021

Phase III topline data reported from ARISE-3 trial of RGN-259 in dry eye

March 18, 2021

Translate Bio reports second interim analysis of phase I/II trial of MRT-5005 for cystic fibrosis

March 18, 2021

High blood fats, sugars alter antigen processing

March 18, 2021

Data flaws sink current AI models for COVID-19 diagnosis

March 18, 2021

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...